Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

A trial update describing a Phase 2/3 study to evaluate the efficacy, safety, and tolerability of dronabinol oral solution for agitation in patients with Alzhei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Dronabinol oral solution (dronabinol)

Snippet

Sponsor: Benuvia Therapeutics Inc. | Conditions: Agitation in Dementia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING